Updated guidelines in Italy call for active screening and multidisciplinary care for women with female genital mutilation because migration reshapes obstetric and gynecologic practices.
Patients with resected Merkel cell carcinoma living in Medicaid expansion states show better stage-specific survival than those in nonexpansion states.
Delayed musculoskeletal symptoms after breast radiotherapy can reflect osteoradionecrosis rather than recurrence, thus supporting a structured conservative management approach.
Dr JoAnn Manson discusses why the FDA’s removal of the ‘black box’ warning on hormone therapy is a long-overdue victory for personalized medicine and shared decision-making.
Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in autoimmune diseases like lupus — but only if patients can get access to them.
Infants who receive nirsevimab may have a lower risk for hospitalisation for RSV-related lower respiratory tract infection than those protected by maternal RSV vaccination.
Medscape Medical News talked with researcher Stacie Dusetzina about the prospects for a single-payer program to help with the very high upfront costs of cell and gene therapies, many of which are in development.
Frank Herd 